A Kansas City, Kan., cancer clinic agreed to pay $2.9 million to resolve allegations that it violated the False Claims Act by submitting claims to Medicare, Medicaid, and the Federal Employee Health Benefits Program without providing those drugs and services.
Do multi-cancer detection tests provide a net benefit? NCI aims to answer this question, beginning with the Vanguard feasibility trial which recently started accruing patients.
